Acumen Share Price

Acumen Share Price

NASDAQ: ABOS | Micro Cap | Healthcare
$0.20
-$0.03 (-12.25%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Acumen Stock Performance

Open
$0.21
Prev. Close
$0.22
Circuit Range
N/A
Day Range
$0.20 - $0.21
Year Range
$0.19 - $3.60
Volume
73,739
Average Traded
$0.20

Acumen Share Price Today

As of 19 November 2026, Acumen Pharmaceuticals, Inc.'s share price is $0.20. The stock opened at $0.21, compared to its previous close of $0.22. During today's trading session, Acumen Pharmaceuticals, Inc.'s share price traded between $0.20 and $0.21, with an average price of $0.21. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $0.19. In terms of performance, Acumen Pharmaceuticals, Inc.'s share price has declined by 92.48% over the last six months and is down 89.59% on a year-on-year basis.

Acumen Share Price Chart

Line chart of the Acumen price trend over the selected period. The price fell overall, ranging from 0.20 to 0.21, ending at 0.20.
$0.20$0.21
L
Show Current Price
H

Acumen Stock Fundamentals & Key Indicators

Market Cap
$11.88M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.44
Revenue (TTM)
$0.00
Return On Equity (TTM)
-300.38%
Profit Margin
N/A
Debt to Equity
0.76
Quarterly Earnings Growth YoY
-0.91%

Acumen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.14-$20.74-$32.72-$25.37
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.50%-57.76%22.46%

Acumen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.86-$52.37-$102.33-$121.34
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.19%-95.40%-18.58%

Acumen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.5860.6963.5116.26
Current Assets122.25178.31246.62180.33
Total Assets122.83238.99310.13196.59
Non Current Liabilities22.429.5730.180.0
Current Liabilities30.0127.6112.977.81
Total Liabilities52.457.1843.157.81
Shareholders' Equity70.43181.82266.97188.78

Acumen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-115.54-86.22-43.06-35.15
Investing133.9348.03-171.6739.19
Financing-0.036.93151.753.91

About Acumen

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Acumen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.20
$0.20
-8.84%
Oct 2026
$2.17
$0.21
-90.34%
Sep 2026
$2.86
$2.23
-26.81%
Aug 2026
$2.13
$3.04
+41.40%
Jul 2026
$2.59
$2.15
-19.17%
Jun 2026
$2.60
$2.66
+1.92%
May 2026
$2.38
$2.61
+9.21%
Apr 2026
$2.46
$2.39
+1.49%
Mar 2026
$3.07
$2.35
-25.59%
Feb 2026
$2.54
$3.17
+21.97%
Jan 2026
$2.09
$2.60
+24.46%
Dec 2025
$1.86
$2.08
+10.61%

Acumen Share Price FAQs